Nemus Bioscience (NMUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NMUS | AMGN | VRTX | REGN | BMY |
| Company | Nemus Bioscience | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.7185 | 278.16 | 392.81 | 890.11 | 44.28 |
| High | 0.7189 | 278.16 | 406.95 | 890.11 | 44.28 |
| Low | 0.6000 | 278.16 | 392.47 | 890.11 | 44.28 |
| Last | 0.6500 | 277.97 | 402.24 | 903.70 | 44.23 |
| Change | -0.0684 | +0.60 | +0.10 | +0.22 | +0.02 |
| % Change | -9.52% | +0.22% | +0.02% | +0.02% | +0.05% |
| Volume | 1,004,500 | 1,239 | 1,256,400 | 3,368 | 15,428 |
| 20-Day Average Volume | 494,515 | 2,120,542 | 999,495 | 456,213 | 13,516,606 |
| Previous Close | 0.7184 | 277.37 | 392.81 | 903.48 | 44.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5046 | 270.19 | 398.90 | 906.78 | 47.86 |
| 20-Day Raw Stochastic | 72.67% | 91.23% | 51.46% | 19.95% | 6.94% |
| 20-Day Relative Strength | 63.72% | 53.50% | 47.81% | 38.80% | 29.10% |
| Weighted Alpha | +34.72 | +15.00 | +14.78 | +14.78 | -36.09 |
| Today's Opinion | 100% Buy | 16% Sell | 8% Buy | 8% Buy | 88% Sell |
| Previous Opinion | 100% Buy | 24% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 40% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +40.54% since 03/15/19 | +3.26% since 04/25/24 | +0.34% since 04/24/24 | -0.06% since 04/25/24 | -0.94% since 04/25/24 |
| Low | 0.4700 on 03/18/19 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.7440 on 03/21/19 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 913.21 on 05/01/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | +31.31% since 02/22/19 | +0.71% since 04/02/24 | -4.36% since 04/01/24 | -6.76% since 04/02/24 | -16.04% since 04/02/24 |
| Low | 0.4000 on 03/11/19 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.7440 on 03/21/19 | 279.84 on 05/01/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 52.87 on 04/03/24 |
| 3-Month | |||||
| %Chg | +62.54% since 12/21/18 | -13.93% since 02/02/24 | -7.31% since 02/01/24 | -5.83% since 02/02/24 | -9.09% since 02/02/24 |
| Low | 0.3000 on 01/31/19 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.7440 on 03/21/19 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +120.34% since 09/21/18 | +4.34% since 11/02/23 | +8.88% since 11/01/23 | +8.71% since 11/02/23 | -13.40% since 11/02/23 |
| Low | 0.0500 on 10/31/18 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 0.7440 on 03/21/19 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 87,040 | 148,774,592 | 103,936,712 | 99,167,768 | 89,618,088 |
| Shares Outstanding, K | 133,908 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -19,190,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -6,220,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | -0.04 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 10/05/18 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.69 | 29.23 | 23.70 | 41.85 |